Navigation Links
Nanotrope, Inc. Receives Patent on New Diagnostic Test for Influenza and Other Viral Infections
Date:11/17/2010

SAN DIEGO, Nov. 17, 2010 /PRNewswire/ -- Nanotrope, Inc. announced today that it has been issued United States patent #7,829,272 covering its ground-breaking diagnostic test for influenza and other viral infections. The patent describes Nanotrope's cellular mimic technology that creates an artificial "cell" engineered with specific membrane compositions and surface receptors which stimulate the virus into infecting the mimic as it would a normal host cell.  Once the cell mimic is infected, viral genome sequences are detected by multi-color fluorescence providing both viral typing and sub-typing capabilities. The sensitivity of the test is comparable to PCR (polymerase chain reaction) detection limits but in a faster, less expensive and simpler format.

The Nanotrope assay may be used to identify any envelope virus, a class of viruses that includes such important infectious disease targets as influenza where the assay can distinguish between seasonal, swine, and pandemic flu strains, RSV, a serious lung disease in young children, West Nile virus, SARS, measles, and rabies. For contagious viral infections, it is important to identify the virus early in the course of the infection so that sick patients may be isolated and properly treated. The high sensitivity, short time to result, and sub-typing capability of the new assay makes it well-suited for hospital and clinical labs where the time to diagnosis is important, as well as for global surveillance for vaccine development.

Nanotrope is a privately held nano-biomaterials company with a focus on developing new products for the pharmaceutical and diagnostic industries. Its expertise in particle technology has enabled a diverse portfolio of intellectual property. The company is actively looking for partners to commercialize its diagnostics technology. Inquiries may be directed to Dr. Donald Ackley at 858-847-7300, don@nanotrope.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Dr. Donald E Ackley

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=99308


'/>"/>
SOURCE Nanotrope, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
2. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
3. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
4. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
5. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
6. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
7. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
8. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
9. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
10. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
11. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... ... International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor Exhibition ... to fill more than 100 tables for its annual event, which will run ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... available on Microsoft Azure. On Azure, Arvados provides capabilities for managing and processing ... demand for Microsoft Azure from major institutions collecting and analyzing genomic data,” said ...
(Date:2/9/2016)... ... 09, 2016 , ... With a presidential election in November and the future ... bring together over 500 top healthcare leaders for a night and day of debates ... by MBA students of the University of Pennsylvania’s Wharton School, will be held February ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... on its free and validated Electronic Data Capture (EDC) system ClinCaptureand its new ... Clinical Trials West Coast 2016 Conference in San Mateo, California on February 10th ...
Breaking Biology Technology:
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 Technology ... service presents an analysis of the digital and computed ... Malaysia , and Indonesia ... current trends and market size, as well as regional ... by country and discusses market penetration and market attractiveness, ...
(Date:2/2/2016)... 2, 2016  Based on its recent analysis ... recognizes US-based Intelligent Retinal Imaging Systems (IRIS) with ... for New Product Innovation. IRIS, a prominent cloud-based ... America , is poised to set the ... retinopathy market. The IRIS technology presents superior price-performance ...
(Date:2/1/2016)... , Feb. 1, 2016  Today, the first day ... announced plans to develop a first of its kind ... of IBM Watson. In the first application of ... (NYSE: IBM ), and Welltok will create a ... assessments with cognitive analytics, delivered on Welltok,s health optimization ...
Breaking Biology News(10 mins):